US Patent No: 6,534,676 B2 UA #03-075 Method to treat chronic heart failure and/or elevated cholesterol with thyroid analog (DITPA) issued 3/18/03, expiration date 5/12/21.
US Patent No: 2002243801 Method to Treat Chronic Heart Failure and/or Elevated Cholesterol Levels using 3,5-Diiodothyropropionic Acid and Method to Prepare Same, Mexico issued 5/2/06, Australia issued 3/22/07, Canada issued 5/14/2011
US Patent No: 7,504,435. Method for Stimulating Weight Loss and/or for Lowering Triglycerides in Patients issued 3/17/09, expiration date 4/13/2025.
US Patent No: 8,399,518. Administration of 3,5-Diiodothyroproprionic Acid for Stimulating Weight Loss, and/or Lowering Triglyceride Levels, and/or Treatment of Metabolic Syndrome issued March 19, 2013, expiration date 9/3/2031.
Seeding and Co-Culture of a 3 Dimensional Fibroblast Construct (3DFC): UA/VA, UA09-061-US provisional patent serial number 61/212,280 and PCT patent application PCT/US10/30579. ssued March 2015.
Jordan Lancaster and I have the following patents that support the IP for this grant submission. The patents have been exclusively licensed to Avery Therapeutics by the University of Arizona.
Lancaster J, Goldman S. Seeding and Co-Culture of a Three Dimensional Fibroblast Construct (3DFC): US9051550, Filed: 4-9-09, Issued: 6-9-15.
Lancaster JJ, Goldman S. Muscle cell patches and uses therefor. US0250384; Filed: 10-9-13, Issued: 6-2017.